Literature DB >> 12628002

An analysis of the phosphorylation and activation of extracellular-signal-regulated protein kinase 5 (ERK5) by mitogen-activated protein kinase kinase 5 (MKK5) in vitro.

Nimesh Mody1, David G Campbell, Nick Morrice, Mark Peggie, Philip Cohen.   

Abstract

MKK5 expressed as a glutathione S-transferase fusion protein in human embryonic kidney 293 cells activated full-length extracellular-signal-regulated protein kinase (ERK)5 (ERK5wt) as well as the isolated catalytic domain (ERK5cat) in vitro. Activation was accompanied by the phosphorylation of Thr(219) and Tyr(221), the former residue being phosphorylated preferentially. ERK5cat phosphorylated at Thr(219), but not Tyr(221), possessed 10% of the activity of the doubly phosphorylated protein towards myelin basic protein, whereas ERK5cat phosphorylated at Tyr(221) alone was much less active. Activated ERK5 phosphorylated itself at a number of residues, including Thr(28), Ser(421), Ser(433), Ser(496), Ser(731) and Thr(733). ERK5 phosphorylated at Thr(219), but not Tyr(221), phosphorylated itself at a similar rate to ERK5 phosphorylated at both Thr(219) and Tyr(221). Activated ERK5 also phosphorylated mitogen-activated protein kinase kinase 5 (MKK5) extensively at Ser(129), Ser(137), Ser(142) and Ser(149), which are located within the region in MKK5 that is thought to interact with ERK5.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12628002      PMCID: PMC1223423          DOI: 10.1042/BJ20030193

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  24 in total

1.  A conserved docking motif in MAP kinases common to substrates, activators and regulators.

Authors:  T Tanoue; M Adachi; T Moriguchi; E Nishida
Journal:  Nat Cell Biol       Date:  2000-02       Impact factor: 28.824

2.  MEKK3 directly regulates MEK5 activity as part of the big mitogen-activated protein kinase 1 (BMK1) signaling pathway.

Authors:  T H Chao; M Hayashi; R I Tapping; Y Kato; J D Lee
Journal:  J Biol Chem       Date:  1999-12-17       Impact factor: 5.157

3.  Specificity and mechanism of action of some commonly used protein kinase inhibitors.

Authors:  S P Davies; H Reddy; M Caivano; P Cohen
Journal:  Biochem J       Date:  2000-10-01       Impact factor: 3.857

4.  Activation of JNK3 alpha 1 requires both MKK4 and MKK7: kinetic characterization of in vitro phosphorylated JNK3 alpha 1.

Authors:  J Lisnock; P Griffin; J Calaycay; B Frantz; J Parsons; S J O'Keefe; P LoGrasso
Journal:  Biochemistry       Date:  2000-03-21       Impact factor: 3.162

5.  BMK1/ERK5 regulates serum-induced early gene expression through transcription factor MEF2C.

Authors:  Y Kato; V V Kravchenko; R I Tapping; J Han; R J Ulevitch; J D Lee
Journal:  EMBO J       Date:  1997-12-01       Impact factor: 11.598

6.  ERK5 is a novel type of mitogen-activated protein kinase containing a transcriptional activation domain.

Authors:  H G Kasler; J Victoria; O Duramad; A Winoto
Journal:  Mol Cell Biol       Date:  2000-11       Impact factor: 4.272

7.  MEKK2 associates with the adapter protein Lad/RIBP and regulates the MEK5-BMK1/ERK5 pathway.

Authors:  W Sun; K Kesavan; B C Schaefer; T P Garrington; M Ware; N L Johnson; E W Gelfand; G L Johnson
Journal:  J Biol Chem       Date:  2000-11-09       Impact factor: 5.157

8.  Synergistic activation of stress-activated protein kinase 1/c-Jun N-terminal kinase (SAPK1/JNK) isoforms by mitogen-activated protein kinase kinase 4 (MKK4) and MKK7.

Authors:  Y Fleming; C G Armstrong; N Morrice; A Paterson; M Goedert; P Cohen
Journal:  Biochem J       Date:  2000-11-15       Impact factor: 3.857

9.  Mechanism of activation of protein kinase B by insulin and IGF-1.

Authors:  D R Alessi; M Andjelkovic; B Caudwell; P Cron; N Morrice; P Cohen; B A Hemmings
Journal:  EMBO J       Date:  1996-12-02       Impact factor: 11.598

10.  Synergistic activation of SAPK1/JNK1 by two MAP kinase kinases in vitro.

Authors:  S Lawler; Y Fleming; M Goedert; P Cohen
Journal:  Curr Biol       Date:  1998 Dec 17-31       Impact factor: 10.834

View more
  29 in total

1.  A MAP kinase kinase interacts with SymRK and regulates nodule organogenesis in Lotus japonicus.

Authors:  Tao Chen; Hui Zhu; Danxia Ke; Kai Cai; Chao Wang; Honglan Gou; Zonglie Hong; Zhongming Zhang
Journal:  Plant Cell       Date:  2012-02-21       Impact factor: 11.277

Review 2.  Modulation of protein kinase signaling cascades by palytoxin.

Authors:  Elizabeth V Wattenberg
Journal:  Toxicon       Date:  2010-11-09       Impact factor: 3.033

Review 3.  Oncogenic signaling of MEK5-ERK5.

Authors:  Van T Hoang; Thomas J Yan; Jane E Cavanaugh; Patrick T Flaherty; Barbara S Beckman; Matthew E Burow
Journal:  Cancer Lett       Date:  2017-01-30       Impact factor: 8.679

4.  ERK5 kinase activity is dispensable for cellular immune response and proliferation.

Authors:  Emme C K Lin; Christopher M Amantea; Tyzoon K Nomanbhoy; Helge Weissig; Junichi Ishiyama; Yi Hu; Shyama Sidique; Bei Li; John W Kozarich; Jonathan S Rosenblum
Journal:  Proc Natl Acad Sci U S A       Date:  2016-09-27       Impact factor: 11.205

Review 5.  MAPK signalling: ERK5 versus ERK1/2.

Authors:  Satoko Nishimoto; Eisuke Nishida
Journal:  EMBO Rep       Date:  2006-08       Impact factor: 8.807

6.  Identification of glycogen synthase as a new substrate for stress-activated protein kinase 2b/p38beta.

Authors:  Yvonne Kuma; David G Campbell; Ana Cuenda
Journal:  Biochem J       Date:  2004-04-01       Impact factor: 3.857

7.  Canonical and kinase activity-independent mechanisms for extracellular signal-regulated kinase 5 (ERK5) nuclear translocation require dissociation of Hsp90 from the ERK5-Cdc37 complex.

Authors:  Tatiana Erazo; Ana Moreno; Gerard Ruiz-Babot; Arantza Rodríguez-Asiain; Nicholas A Morrice; Josep Espadamala; Jose R Bayascas; Nestor Gómez; Jose M Lizcano
Journal:  Mol Cell Biol       Date:  2013-02-19       Impact factor: 4.272

8.  Extracellular signal regulated kinase 5 mediates signals triggered by the novel tumor promoter palytoxin.

Authors:  Aaron T Charlson; Nicholette A Zeliadt; Elizabeth V Wattenberg
Journal:  Toxicol Appl Pharmacol       Date:  2009-08-28       Impact factor: 4.219

9.  MEK5 and ERK5 are mediators of the pro-myogenic actions of IGF-2.

Authors:  Emma J Carter; Ruth A Cosgrove; Ivelisse Gonzalez; Joan H Eisemann; Fiona A Lovett; Laura J Cobb; Jennifer M Pell
Journal:  J Cell Sci       Date:  2009-08-04       Impact factor: 5.285

10.  Extracellular signal-regulated kinase 5 promotes acute cellular and systemic inflammation.

Authors:  Kevin Wilhelmsen; Fengyun Xu; Katherine Farrar; Alphonso Tran; Samira Khakpour; Shirin Sundar; Arun Prakash; Jinhua Wang; Nathanael S Gray; Judith Hellman
Journal:  Sci Signal       Date:  2015-08-25       Impact factor: 8.192

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.